Drachman, Jonathan G. External Entity

Publications

Sort by

Selected publications

  • A phase II study of dacetuzumab (SGN-40) in patients with relapsed diffuse large B-cell lymphoma (DLBCL) and correlative analyses of patient-specific factors.  Journal of hematology & oncology2014 Academic Article GET IT

Other